These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34619001)

  • 41. [Generalized hyperpigmentation and malignant acanthosis nigricans. A case of a patient with hereditary hemochromatosis and gastric cancer].
    Kalt A; Wagner A; Zeuzem S; Tilgen W; Reichrath J
    Hautarzt; 2005 Jun; 56(6):581-5. PubMed ID: 15645193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved acanthosis nigricans with lipodystrophic diabetes during dietary fish oil supplementation.
    Sherertz EF
    Arch Dermatol; 1988 Jul; 124(7):1094-6. PubMed ID: 3389852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malignant acanthosis nigricans associated with prostate cancer: a case report.
    Kubicka-Wołkowska J; Dębska-Szmich S; Lisik-Habib M; Noweta M; Potemski P
    BMC Urol; 2014 Nov; 14():88. PubMed ID: 25399333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fractional Carbon Dioxide Laser versus Trichloroacetic Acid 20% Peel in the Treatment of Acanthosis Nigricans: A Split Neck Comparative Study.
    Fouda I; Shatta AS; Obaid ZM
    J Clin Aesthet Dermatol; 2023 Nov; 16(11):36-41. PubMed ID: 38076653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acral acanthosis nigricans associated with taking growth hormone].
    Peña Irún A
    Semergen; 2014; 40(4):e77-9. PubMed ID: 23746703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with acanthosis nigricans in obese adolescents.
    Galhardo J; Hunt LP; Shield JP
    Diabet Med; 2012 Jul; 29(7):e117-20. PubMed ID: 22288782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream.
    Adigun CG; Pandya AG
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):486-7. PubMed ID: 18721216
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative study between fractional carbon dioxide laser versus retinoic acid chemical peel in the treatment of acanthosis nigricans.
    Abu Oun AA; Ahmed NA; Hafiz HSA
    J Cosmet Dermatol; 2022 Mar; 21(3):1023-1030. PubMed ID: 33998772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acanthosis nigricans-like hyperpigmentation secondary to triazinate therapy.
    Greenspan AH; Shupack JL; Foo SH; Wise AC
    Arch Dermatol; 1985 Feb; 121(2):232-5. PubMed ID: 3977338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case series of acanthosis nigricans treated with topical trifarotene cream.
    Lee WG; Koh YG; Shin SH; Park KY; Lee HW
    J Cosmet Dermatol; 2023 Oct; 22(10):2862-2864. PubMed ID: 37060202
    [No Abstract]   [Full Text] [Related]  

  • 51. Trichloroacetic Acid 15% Peel Alone versus in Combination with Microneedling in Patients with Acanthosis Nigricans.
    Khashaba SA; Alaa S; Eldeeb F
    J Clin Aesthet Dermatol; 2024 Apr; 17(4):28-32. PubMed ID: 38638182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case of hyperpigmentation and acanthosis nigricans by testosterone injections.
    Karadag A; Kavala M; Demir F; Turkoğlu Z; Kartal I; Zemheri E
    Hum Exp Toxicol; 2014 Dec; 33(12):1297-301. PubMed ID: 24505054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The autosomal dominant trait of obesity, acanthosis nigricans, hypertension, ischemic heart disease and diabetes type 2.
    Kerem N; Guttmann H; Hochberg Z
    Horm Res; 2001; 55(6):298-304. PubMed ID: 11805435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation.
    Ichiyama S; Funasaka Y; Otsuka Y; Takayama R; Kawana S; Saeki H; Kubo A
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):442-5. PubMed ID: 26818779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of acanthosis nigricans with metabolic syndrome in obese children.
    Daye M; Selver Eklioglu B; Atabek ME
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1563-1568. PubMed ID: 33581705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generalized acanthosis nigricans in an otherwise healthy young child.
    Uyttendaele H; Koss T; Bagheri B; Schneiderman P; Silfen ME; Gallagher MP; Garzon M; Engler D
    Pediatr Dermatol; 2003; 20(3):254-6. PubMed ID: 12787277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fractional carbon dioxide laser versus trichloroacetic acid peel in the treatment of pseudo-acanthosis nigricans.
    Eldeeb F; Wahid RM; Alakad R
    J Cosmet Dermatol; 2022 Jan; 21(1):247-253. PubMed ID: 33749961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
    Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
    J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acanthosis nigricans.
    Stuart CA; Driscoll MS; Lundquist KF; Gilkison CR; Shaheb S; Smith MM
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):407-18. PubMed ID: 10212845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic implications of dermoscopic findings in acanthosis nigricans: A clinical and histopathological study.
    Pardeshi SS; Khemani UN; Kamath RR; Kura MM; Jafferany M
    Dermatol Ther; 2020 Nov; 33(6):e14521. PubMed ID: 33176058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.